Literature DB >> 30414458

Intracellular antigen processing by ERAP2: Molecular mechanism and roles in health and disease.

José A López de Castro1, Efstratios Stratikos2.   

Abstract

Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) is an intracellular enzyme localized in the ER that has been shown to play roles in the generation of peptides that serve as ligands for MHC class I (MHC-1) molecules. Although ERAP2 has been primarily described as an accessory and complementary enzyme to the homologous ERAP1, several lines of evidence during the last few years suggest that it can play distinct and important roles in processing antigenic peptides and influencing cellular cytotoxic immune responses. Such emerging evidence has been shaping ERAP2 as a potentially tractable target for regulating select autoimmune and anti-cancer responses for therapeutic purposes. Here, we review the state-of-the-art knowledge on the role of ERAP2 in antigen processing, its structure and molecular mechanism, influence on shaping MHC-I-bound immunopeptidomes and its involvement in disease pathogenesis.
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30414458     DOI: 10.1016/j.humimm.2018.11.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

2.  Inhibitor-Dependent Usage of the S1' Specificity Pocket of ER Aminopeptidase 2.

Authors:  Anastasia Mpakali; Dimitris Georgiadis; Efstratios Stratikos; Petros Giastas
Journal:  ACS Med Chem Lett       Date:  2022-01-13       Impact factor: 4.345

3.  Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target-Guided Synthesis.

Authors:  Virgyl Camberlein; Charlotte Fléau; Pierre Sierocki; Lenong Li; Ronan Gealageas; Damien Bosc; Valentin Guillaume; Sandrine Warenghem; Florence Leroux; Melissa Rosell; Keguang Cheng; Laura Medve; Mathilde Prigent; Myriam Decanter; Catherine Piveteau; Alexandre Biela; Maxime Eveque; Julie Dumont; Anastasia Mpakali; Petros Giastas; Adrien Herledan; Cyril Couturier; Jörg Haupenthal; Laetitia Lesire; Anna K H Hirsch; Benoit Deprez; Efstratios Stratikos; Marlene Bouvier; Rebecca Deprez-Poulain
Journal:  Angew Chem Int Ed Engl       Date:  2022-08-19       Impact factor: 16.823

4.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

Review 5.  ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?

Authors:  Silvia D'Amico; Patrizia Tempora; Valeria Lucarini; Ombretta Melaiu; Stefania Gaspari; Mattia Algeri; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

6.  ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides.

Authors:  Ioannis Temponeras; George Stamatakis; Martina Samiotaki; Dimitris Georgiadis; Harris Pratsinis; George Panayotou; Efstratios Stratikos
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

7.  Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection.

Authors:  Irma Saulle; Salomè Valentina Ibba; Enrica Torretta; Cecilia Vittori; Claudio Fenizia; Federica Piancone; Davide Minisci; Elisa Maria Lori; Daria Trabattoni; Cecilia Gelfi; Mario Clerici; Mara Biasin
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

Review 8.  An Overview on ERAP Roles in Infectious Diseases.

Authors:  Irma Saulle; Chiara Vicentini; Mario Clerici; Mara Biasin
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

9.  A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?

Authors:  Irma Saulle; Claudia Vanetti; Sara Goglia; Chiara Vicentini; Enrico Tombetti; Micaela Garziano; Mario Clerici; Mara Biasin
Journal:  Cells       Date:  2020-08-24       Impact factor: 6.600

10.  Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties.

Authors:  Jonathan P Hutchinson; Ioannis Temponeras; Jonas Kuiper; Adrian Cortes; Justyna Korczynska; Semra Kitchen; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2021-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.